Ken Griffin’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$169M Sell
1,966,114
-573,282
-23% -$51.5M 0.03% 521
2025
Q4
$222M Buy
2,539,396
+2,427,303
+2,165% +$184M 0.03% 442
2025
Q3
$6.42M Buy
+112,093
New +$6.45M ﹤0.01% 3922
2025
Q2
Sell
-285,347
Closed -$18.4M 13461
2025
Q1
$20.9M Sell
285,347
-2,286,313
-89% -$189M ﹤0.01% 1991
2024
Q4
$213M Buy
2,571,660
+985,036
+62% +$77.7M 0.04% 384
2024
Q3
$114M Buy
1,586,624
+806,296
+103% +$56.9M 0.02% 625
2024
Q2
$53.4M Buy
780,328
+208,399
+36% +$12.5M 0.01% 1106
2024
Q1
$30.7M Buy
571,929
+462,770
+424% +$24.9M 0.01% 1643
2023
Q4
$5.82M Buy
109,159
+4,415
+4% +$215K ﹤0.01% 3571
2023
Q3
$5.2M Sell
104,744
-189,788
-64% -$10.6M ﹤0.01% 3585
2023
Q2
$17.5M Sell
294,532
-834,133
-74% -$47.5M ﹤0.01% 2020
2023
Q1
$63.9M Buy
1,128,665
+997,390
+760% +$64M 0.01% 891
2022
Q4
$9.75M Sell
131,275
-13,398
-9% -$912K ﹤0.01% 2879
2022
Q3
$8.62M Buy
144,673
+125,382
+650% +$7.55M ﹤0.01% 2988
2022
Q2
$1.08M Sell
19,291
-73,087
-79% -$4.8M ﹤0.01% 6835
2022
Q1
$6.82M Buy
92,378
+34,647
+60% +$2.41M ﹤0.01% 3592
2021
Q4
$4.17M Buy
57,731
+39,627
+219% +$2.88M ﹤0.01% 4660
2021
Q3
$1.39M Sell
18,104
-54,496
-75% -$4.38M ﹤0.01% 7302
2021
Q2
$5.63M Buy
72,600
+13,925
+24% +$990K ﹤0.01% 4178
2021
Q1
$3.62M Sell
58,675
-143,276
-71% -$9.07M ﹤0.01% 5006
2020
Q4
$13.2M Buy
201,951
+175,630
+667% +$10.1M ﹤0.01% 2282
2020
Q3
$1.3M Sell
26,321
-74,975
-74% -$3.87M ﹤0.01% 5544
2020
Q2
$4.83M Buy
101,296
+36,054
+55% +$1.74M ﹤0.01% 3133
2020
Q1
$2.77M Sell
65,242
-161,526
-71% -$7.98M ﹤0.01% 3590
2019
Q4
$13.4M Buy
226,768
+207,810
+1,096% +$11.3M 0.01% 1902
2019
Q3
$969K Sell
18,958
-46,758
-71% -$2.23M ﹤0.01% 5654
2019
Q2
$2.78M Sell
65,716
-93,326
-59% -$4.05M ﹤0.01% 3983
2019
Q1
$7.86M Buy
159,042
+153,312
+2,676% +$6.94M ﹤0.01% 2367
2018
Q4
$248K Buy
+5,730
New +$286K ﹤0.01% 7558
2018
Q3
Sell
-85,898
Closed -$4.52M 9392
2018
Q2
$4.33M Buy
85,898
+42,293
+97% +$2.21M ﹤0.01% 2953
2018
Q1
$2.17M Buy
43,605
+34,488
+378% +$1.62M ﹤0.01% 3613
2017
Q4
$375K Sell
9,117
-4,856
-35% -$170K ﹤0.01% 6103
2017
Q3
$415K Sell
13,973
-24,023
-63% -$734K ﹤0.01% 5587
2017
Q2
$1.26M Sell
37,996
-374,813
-91% -$11.8M ﹤0.01% 3769
2017
Q1
$12.2M Buy
412,809
+396,496
+2,431% +$10.8M 0.01% 1291
2016
Q4
$405K Sell
16,313
-413,980
-96% -$9.41M ﹤0.01% 5230
2016
Q3
$9.71M Buy
430,293
+253,372
+143% +$5.95M 0.01% 1384
2016
Q2
$4.22M Sell
176,921
-44,408
-20% -$1.07M ﹤0.01% 1963
2016
Q1
$5.26M Buy
221,329
+182,818
+475% +$4.47M 0.01% 1717
2015
Q4
$1.07M Sell
38,511
-210,304
-85% -$5.28M ﹤0.01% 3478
2015
Q3
$5.14M Buy
248,815
+139,065
+127% +$3.52M ﹤0.01% 1924
2015
Q2
$2.82M Buy
109,750
+83,137
+312% +$2.11M ﹤0.01% 2657
2015
Q1
$672K Sell
26,613
-67,525
-72% -$1.65M ﹤0.01% 4487
2014
Q4
$2.24M Buy
94,138
+17,755
+23% +$393K ﹤0.01% 2784
2014
Q3
$1.5M Sell
76,383
-45,226
-37% -$931K ﹤0.01% 3200
2014
Q2
$2.91M Buy
121,609
+81,870
+206% +$1.97M ﹤0.01% 2368
2014
Q1
$1.06M Sell
39,739
-67
-0.2% -$1.59K ﹤0.01% 3346
2013
Q4
$804K Buy
39,806
+25,562
+179% +$475K ﹤0.01% 3449
2013
Q3
$249K Buy
+14,244
New +$247K ﹤0.01% 4550

Other funds holding GMED

Ken Griffin's GMED Position: Q1 2026 in Review

Ken Griffin reduced its Globus Medical (GMED) stake by 23% in Q1 2026, selling an estimated $51.5M and leaving 1,966,114 shares worth $169M. The position accounts for 0.03% of the portfolio, ranked #521.

Ken Griffin first reported a position in GMED in Q3 2013 and has held it in 49 quarters since. The position peaked at $222M in Q4 2025. 605 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Ken Griffin held 1,966,114 shares of Globus Medical worth $169M as of Q1 2026.
  • Ken Griffin sold 573,282 Globus Medical shares in Q1 2026, an estimated $51.5M.
  • Globus Medical made up 0.03% of Ken Griffin's portfolio in Q1 2026, its #521 holding.
  • Ken Griffin first reported a position in Globus Medical in Q3 2013 and has held it in 49 quarters since.
  • Ken Griffin's Globus Medical position peaked at $222M in Q4 2025.
  • 605 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.